Medical Properties Trust (NYSE:MPT – Get Free Report) announced its earnings results on Monday. The company reported $0.15 EPS for the quarter, hitting analysts’ consensus estimates of $0.15, Briefing.com reports. The business had revenue of $259.28 million during the quarter. Medical Properties Trust had a negative net margin of 12.59% and a negative return on equity of 2.70%. The company’s revenue was up 7.9% compared to the same quarter last year.
Here are the key takeaways from Medical Properties Trust’s conference call:
- Refinancing materially reduces near-term debt risk: MPT plans to eliminate all 2026 and 2027 maturities, leaving only approximately $600 million due in June 2028 and improving its unencumbered-assets-to-unsecured-debt covenant cushion toward as much as 300%.
- Management expects up to $1.1 billion of liquidity from asset sales and cited recent and pending transactions that value hospital assets above book value, including approximately $172 million of near-term after-debt proceeds and a potential additional $200 million to $400 million from other negotiations.
- Second-quarter normalized FFO was $0.15 per share, up from $0.14 in the prior quarter, while portfolio performance was mixed: post-acute operators remained strong, general acute was stable, and behavioral health coverage declined to 1.4 times.
- HSA remains a key risk as cash collections stayed in the 80% range after an electronic medical-record conversion, revenue-cycle transition, and delayed Florida supplemental payments; management is cautiously optimistic but said collections must improve substantially.
- Noor paid 50% contractual rent beginning in June and is showing improving admissions, emergency-department visits, and surgeries, while Ernest Health continues to perform strongly and is adding seven hospitals through its Reunion Rehabilitation acquisition.
Medical Properties Trust Price Performance
Shares of MPT stock opened at $4.14 on Tuesday. The stock has a fifty day moving average price of $4.70. Medical Properties Trust has a 1 year low of $3.95 and a 1 year high of $6.47. The company has a debt-to-equity ratio of 2.13, a current ratio of 3.11 and a quick ratio of 3.11. The stock has a market cap of $2.48 billion, a price-to-earnings ratio of -19.71 and a beta of 1.41.
Medical Properties Trust Announces Dividend
Wall Street Analysts Forecast Growth
MPT has been the topic of a number of analyst reports. Weiss Ratings downgraded shares of Medical Properties Trust from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Tuesday, August 4th. Royal Bank Of Canada decreased their target price on shares of Medical Properties Trust from $5.00 to $4.50 and set a “sector perform” rating for the company in a research report on Thursday, June 18th. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Reduce” and an average target price of $4.50.
View Our Latest Analysis on MPT
Key Stories Impacting Medical Properties Trust
Here are the key news stories impacting Medical Properties Trust this week:
- Positive Sentiment: MPT agreed to a $2.4 billion private refinancing transaction, a potentially important development that could reduce near-term refinancing and liquidity risk and improve visibility around its debt obligations. Medical Properties Trust agrees to $2.4B private refinancing deal
- Positive Sentiment: Second-quarter revenue increased 7.9% year over year to $259.28 million, with billed rent stronger than expected. The performance suggests improving portfolio cash-collection trends, even though the company continues to face broader financial challenges. Medical Properties Trust Q2 revenue beats on stronger-than-expected billed rent
- Neutral Sentiment: MPT reported second-quarter earnings of $0.15 per share, matching the consensus estimate. The earnings result was steady, but the company posted a negative net margin of 12.59% and negative return on equity of 2.70%, limiting the positive impact. Medical Properties Q2 Earnings Snapshot
- Negative Sentiment: Funds from operations (FFO) came in at $0.15 per share, below the $0.16 consensus estimate. Although FFO improved from $0.14 a year earlier, the miss may weigh on the stock because FFO is a key measure for real estate investment trusts. Medical Properties Q2 FFO Miss Estimates
- Negative Sentiment: Investors purchased 88,203 put options on Monday, roughly 776% above typical daily put volume. The unusual activity signals elevated near-term hedging or bearish speculation, though it does not necessarily predict the company’s long-term performance.
About Medical Properties Trust
Medical Properties Trust, Inc (NYSE: MPT) is a real estate investment trust (REIT) that acquires, owns and finances hospitals and other healthcare facilities. Founded in 2003 by Edward K. Aldag Jr., the company’s business model centers on providing real estate capital to healthcare operators through long-term leases, sale-leaseback transactions, build-to-suit developments and mortgage financing. By specializing in healthcare real estate, MPT aims to deliver steady rental income and asset-based returns while enabling operators to access capital for clinical operations and growth.
The company’s portfolio primarily comprises acute care hospitals, inpatient rehabilitation hospitals, long-term acute care facilities, behavioral health centers and other specialty hospitals.
Read More
- Five stocks we like better than Medical Properties Trust
- 3 Overlooked Stocks Analysts Still Like as AI Trades Get Crowded
- China’s Athleisure Boom Is Not Lifting Every Brand Equally
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.
